Abbott rakes in earnings despite infant formula investigation but Nutrition suffers sales loss
date:Jul 22, 2022
s important to note that the results of the investigation from the FDA, Centers for Disease Control and Prevention and Abbott concluded no evidence linked our formulas to any infant illnesses or deaths, and there is no new information to suggest otherwise. We take this matter very seriously, and were making a number of enhancements to our operations at the impacted manufacturing plant, Ford stresses.

Cutting costs
Not even two weeks after Abbott Nutrition restarted production in Sturgis, the c
8/11 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/20 05:27